TAKHZYRO is a prescription medicine used to prevent attacks of hereditary angioedema (HAE) in people 12 years of age and older. It is not known if TAKHZYRO is safe and effective in children under 12 years of age.

FREQUENTLY ASKED QUESTIONS

Have questions about TAKHZYRO? This is the place to find answers.

You can also ask your healthcare provider for more information.

What is TAKHZYRO?

TAKHZYRO is a prescription medicine used to prevent attacks of hereditary angioedema (HAE) in people 12 years of age and older. It is not known if TAKHZYRO is safe and effective in children under 12 years of age.

How does TAKHZYRO work?

TAKHZYRO prevents a protein called kallikrein from starting a reaction that leads to HAE attacks.

What should I tell my healthcare provider before taking TAKHZYRO?

You should tell your healthcare provider about all of your medical conditions, including if you are pregnant or planning to become pregnant. It is not known if TAKHZYRO can harm your unborn baby.

You should also tell your healthcare provider if you are breastfeeding or plan to breastfeed. It is not known if TAKHZYRO passes into your breastmilk, so you should talk to your healthcare provider about the best way to feed your baby while using TAKHZYRO.

Can I take other medications with TAKHZYRO?

You should tell your healthcare provider about all the medicines you take, including prescription medicines, over-the-counter medicines, vitamins, or herbal supplements.

What are the possible side effects of TAKHZYRO?

TAKHZYRO may cause serious side effects, including allergic reactions. Call your healthcare provider or get emergency help right away if you have any of the following symptoms:

  • wheezing
  • difficulty breathing
  • chest tightness
  • fast heartbeat
  • faintness
  • rash
  • hives

The most common side effects seen with TAKHZYRO were injection site reactions (pain, redness, and bruising), upper respiratory infection, and headache.

Tell your healthcare provider if you have any side effect that bothers you or that does not go away. These are not all the possible side effects of TAKHZYRO. For more information, ask your healthcare provider or pharmacist.

Call your doctor for medical advice about side effects. You may report side effects to the FDA at 1–800–FDA–1088.

Can I administer TAKHZYRO myself?

Yes. Once you have been trained by a healthcare provider, you can administer TAKHZYRO yourself.

How do I take TAKHZYRO?

TAKHZYRO is administered by subcutaneous (under-the-skin) injection. The recommended dose is 300 mg every 2 weeks for people starting on TAKHZYRO. There are 3 choices for the injection site (stomach [abdomen], either thigh, or either arm).

You should read the detailed "Instructions for Use" that comes with the Prescribing Information about the right way to prepare and inject TAKHZYRO. Do not try to inject TAKHZYRO unless you have been trained by your healthcare provider.

Does TAKHZYRO come ready to use?

Yes. There is no reconstitution needed.

How do I store TAKHZYRO?

TAKHZYRO should be kept in the refrigerator between 36°F and 46°F (2°C and 8°C). Do not freeze TAKHZYRO. Make sure you keep TAKHZYRO in the original carton to protect it from light, and do not use it after the expiration date on the vial.

Do not shake TAKHZYRO. Always keep TAKHZYRO and all medicines out of the reach of children.

WHAT IS TAKHZYRO?

TAKHZYRO is a prescription medicine used to prevent attacks of hereditary angioedema (HAE) in people 12 years of age and older.

It is not known if TAKHZYRO is safe and effective in children under 12 years of age.

IMPORTANT SAFETY INFORMATION

TAKHZYRO may cause serious side effects, including allergic reactions. Call your healthcare provider or get emergency help right away if you have any of the following symptoms:

  • wheezing
  • difficulty breathing
  • chest tightness
  • fast heartbeat
  • faintness
  • rash
  • hives

The most common side effects seen with TAKHZYRO were injection site reactions (pain, redness, and bruising), upper respiratory infection, and headache.

These are not all the possible side effects of TAKHZYRO. For more information, ask your healthcare provider or pharmacist. You may report side effects to the FDA at 1–800–FDA–1088.

TAKHZYRO has not been studied in pregnant or breastfeeding women. Talk to your healthcare provider about the risk of taking TAKHZYRO if you are pregnant, plan to be pregnant, are breastfeeding, or plan to breastfeed.

Please see full Prescribing Information, including information for patients.